These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 1328386)
41. B-lineage lymphoid blast crisis in juvenile chronic myelogenous leukemia: II. Interleukin-1-mediated autocrine growth regulation of the lymphoblasts. Attias D; Grunberger T; Vanek W; Estrov Z; Cohen A; Lau R; Freedman MH Leukemia; 1995 May; 9(5):884-8. PubMed ID: 7769852 [TBL] [Abstract][Full Text] [Related]
42. Transcriptional regulation of the interferon-beta 2/B cell differentiation factor BSF-2/hepatocyte-stimulating factor gene in human fibroblasts by other cytokines. Walther Z; May LT; Sehgal PB J Immunol; 1988 Feb; 140(3):974-7. PubMed ID: 3276786 [TBL] [Abstract][Full Text] [Related]
43. Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha. Aloisi F; Carè A; Borsellino G; Gallo P; Rosa S; Bassani A; Cabibbo A; Testa U; Levi G; Peschle C J Immunol; 1992 Oct; 149(7):2358-66. PubMed ID: 1382099 [TBL] [Abstract][Full Text] [Related]
44. IL-2 and a contact-mediated signal provided by TCR alpha beta + or TCR gamma delta + CD4+ T cells induce polyclonal Ig production by committed human B cells. Enhancement by IL-5, specific inhibition of IgA synthesis by IL-4. van Vlasselaer P; Gascan H; de Waal Malefyt R; de Vries JE J Immunol; 1992 Mar; 148(6):1674-84. PubMed ID: 1347306 [TBL] [Abstract][Full Text] [Related]
45. Cytokine secretion by C3H-lpr and -gld T cells. Hypersecretion of IFN-gamma and tumor necrosis factor-alpha by stimulated CD4+ T cells. Davidson WF; Calkins C; Hügins A; Giese T; Holmes KL J Immunol; 1991 Jun; 146(12):4138-48. PubMed ID: 1674953 [TBL] [Abstract][Full Text] [Related]
46. HIV replication in IL-2-stimulated peripheral blood mononuclear cells is driven in an autocrine/paracrine manner by endogenous cytokines. Kinter AL; Poli G; Fox L; Hardy E; Fauci AS J Immunol; 1995 Mar; 154(5):2448-59. PubMed ID: 7868911 [TBL] [Abstract][Full Text] [Related]
47. In vitro cultured stromal cells from human tonsils display a distinct phenotype and induce B cell adhesion and proliferation. Lisignoli G; Monaco MC; Facchini A; Toneguzzi S; Cattini L; Hilbert DM; Lavaroni S; Belvedere O; Degrassi A Eur J Immunol; 1996 Jan; 26(1):17-27. PubMed ID: 8566062 [TBL] [Abstract][Full Text] [Related]
48. Essential role of tumor necrosis factor-alpha in the differentiation of human tonsil in vivo induced B cells capable of spontaneous and high-rate immunoglobulin secretion. Rodríguez C; Roldán E; Navas G; Brieva JA Eur J Immunol; 1993 May; 23(5):1160-4. PubMed ID: 8477810 [TBL] [Abstract][Full Text] [Related]
49. Interleukin 1 alpha acts as an autocrine growth factor for RPMI 1788, an Epstein-Barr virus-transformed human B cell line. Vandenabeele P; Jayaram B; Devos R; Shaw A; Fiers W Eur J Immunol; 1988 Jul; 18(7):1027-31. PubMed ID: 2841138 [TBL] [Abstract][Full Text] [Related]
50. Functional and molecular characterization of B cell line derived interleukin-1 alpha. Vyth-Dreese FA; Hekman A; Wijffels J; Geertsma M; Dellemijn TA; Dosda J; Melief CJ; Bertoglio J Leukemia; 1989 Aug; 3(8):585-92. PubMed ID: 2787453 [TBL] [Abstract][Full Text] [Related]
51. Heterogeneity in response to interleukin 6 (IL-6), expression of IL-6 and IL-6 receptor mRNA in a panel of established human multiple myeloma cell lines. Jernberg H; Pettersson M; Kishimoto T; Nilsson K Leukemia; 1991 Mar; 5(3):255-65. PubMed ID: 1707469 [TBL] [Abstract][Full Text] [Related]
52. Tumor necrosis factor as an autocrine growth factor for neuroblastoma. Goillot E; Combaret V; Ladenstein R; Baubet D; Blay JY; Philip T; Favrot MC Cancer Res; 1992 Jun; 52(11):3194-200. PubMed ID: 1317260 [TBL] [Abstract][Full Text] [Related]
53. Interleukin-1 and tumor necrosis factor: effector cytokines in autoimmune diseases. Dinarello CA Semin Immunol; 1992 Jun; 4(3):133-45. PubMed ID: 1320950 [TBL] [Abstract][Full Text] [Related]
55. Molecular investigation of the cytokines produced by normal and malignant B lymphocytes. Schena M; Gaidano G; Gottardi D; Malavasi F; Larsson LG; Nilsson K; Caligaris-Cappio F Leukemia; 1992 Feb; 6(2):120-5. PubMed ID: 1372670 [TBL] [Abstract][Full Text] [Related]
56. Cytokine-induced release of plasminogen activator inhibitor-1 by human mesothelial cells. Whawell SA; Thompson JN Eur J Surg; 1995 May; 161(5):315-8. PubMed ID: 7662773 [TBL] [Abstract][Full Text] [Related]
57. Human osteoblastlike cells do not respond to interleukin-6. Littlewood AJ; Aarden LA; Evans DB; Russell RG; Gowen M J Bone Miner Res; 1991 Feb; 6(2):141-8. PubMed ID: 1709332 [TBL] [Abstract][Full Text] [Related]
58. Increase in interleukin 6 (IL-6) and IL-6 receptor expression in a human multiple myeloma cell line, U-266, during long-term in vitro culture and the development of a possible autocrine IL-6 loop. Jernberg-Wiklund H; Pettersson M; Carlsson M; Nilsson K Leukemia; 1992 Apr; 6(4):310-8. PubMed ID: 1588793 [TBL] [Abstract][Full Text] [Related]
59. Expression of tumour necrosis factor-alpha, -beta and interferon-gamma genes within human neuroglial tumour cells and brain specimens. Nitta T; Ebato M; Sato K; Okumura K Cytokine; 1994 Mar; 6(2):171-80. PubMed ID: 8032000 [TBL] [Abstract][Full Text] [Related]
60. Cytokines as positive and negative regulators of tumor promotion and progression. Michiel DF; Oppenheim JJ Semin Cancer Biol; 1992 Feb; 3(1):3-15. PubMed ID: 1322742 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]